- call +1-201-465-4211
- email sales@mrinsights.biz
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Scope of the Report:
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.
The worldwide market for Oncology Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Oncology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
Market Segment by Applications, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology Drugs, with price, sales, revenue and global market share of Oncology Drugs in 2017 and 2018.
Chapter 3, the Oncology Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oncology Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oncology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Antimetabolite
1.2.2 Alkaloid drugs
1.2.3 Hormone
1.2.4 Targeted drug
1.2.5 Platinum-based drugs
1.2.6 Other
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Oncology Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 HENGRUI
2.2.1 Business Overview
2.2.2 Oncology Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 HENGRUI Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Oncology Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 QILU
2.4.1 Business Overview
2.4.2 Oncology Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 QILU Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Oncology Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 HANSOH
2.6.1 Business Overview
2.6.2 Oncology Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 HANSOH Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 LUYE
2.7.1 Business Overview
2.7.2 Oncology Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LUYE Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Oncology Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 GuiZhou YiBai
2.9.1 Business Overview
2.9.2 Oncology Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GuiZhou YiBai Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Lunan
2.10.1 Business Overview
2.10.2 Oncology Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lunan Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Eli Lilly and Company
2.11.1 Business Overview
2.11.2 Oncology Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eli Lilly and Company Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oncology Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Oncology Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Oncology Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Oncology Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Oncology Drugs Market Analysis by Regions
4.1 Global Oncology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Oncology Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Oncology Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Oncology Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Oncology Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Oncology Drugs Sales and Growth Rate (2014-2019)
4.5 South America Oncology Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Oncology Drugs Sales and Growth Rate (2014-2019)
5 North America Oncology Drugs by Country
5.1 North America Oncology Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Oncology Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Oncology Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Oncology Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Oncology Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Oncology Drugs Sales and Growth Rate (2014-2019)
6 Europe Oncology Drugs by Country
6.1 Europe Oncology Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Oncology Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Oncology Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Oncology Drugs Sales and Growth Rate (2014-2019)
6.3 UK Oncology Drugs Sales and Growth Rate (2014-2019)
6.4 France Oncology Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Oncology Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Oncology Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Oncology Drugs by Country
7.1 Asia-Pacific Oncology Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Oncology Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Oncology Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Oncology Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Oncology Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Oncology Drugs Sales and Growth Rate (2014-2019)
7.5 India Oncology Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Oncology Drugs Sales and Growth Rate (2014-2019)
8 South America Oncology Drugs by Country
8.1 South America Oncology Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Oncology Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Oncology Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Oncology Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Oncology Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Oncology Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Oncology Drugs by Countries
9.1 Middle East and Africa Oncology Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Oncology Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Oncology Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Oncology Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Oncology Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Oncology Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Oncology Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Oncology Drugs Sales and Growth Rate (2014-2019)
10 Global Oncology Drugs Market Segment by Type
10.1 Global Oncology Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Oncology Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Oncology Drugs Revenue and Market Share by Type (2014-2019)
10.2 Antimetabolite Sales Growth and Price
10.2.1 Global Antimetabolite Sales Growth (2014-2019)
10.2.2 Global Antimetabolite Price (2014-2019)
10.3 Alkaloid drugs Sales Growth and Price
10.3.1 Global Alkaloid drugs Sales Growth (2014-2019)
10.3.2 Global Alkaloid drugs Price (2014-2019)
10.4 Hormone Sales Growth and Price
10.4.1 Global Hormone Sales Growth (2014-2019)
10.4.2 Global Hormone Price (2014-2019)
10.5 Targeted drug Sales Growth and Price
10.5.1 Global Targeted drug Sales Growth (2014-2019)
10.5.2 Global Targeted drug Price (2014-2019)
10.6 Platinum-based drugs Sales Growth and Price
10.6.1 Global Platinum-based drugs Sales Growth (2014-2019)
10.6.2 Global Platinum-based drugs Price (2014-2019)
10.7 Other Sales Growth and Price
10.7.1 Global Other Sales Growth (2014-2019)
10.7.2 Global Other Price (2014-2019)
11 Global Oncology Drugs Market Segment by Application
11.1 Global Oncology Drugs Sales Market Share by Application (2014-2019)
11.2 Blood Cancer Sales Growth (2014-2019)
11.3 Breast Cancer Sales Growth (2014-2019)
11.4 Gastrointestinal Cancer Sales Growth (2014-2019)
11.5 Prostate Cancer Sales Growth (2014-2019)
11.6 Respiratory/Lung Cancer Sales Growth (2014-2019)
11.7 Other Sales Growth (2014-2019)
12 Oncology Drugs Market Forecast (2019-2024)
12.1 Global Oncology Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Oncology Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Oncology Drugs Market Forecast (2019-2024)
12.2.2 Europe Oncology Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Oncology Drugs Market Forecast (2019-2024)
12.2.4 South America Oncology Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Oncology Drugs Market Forecast (2019-2024)
12.3 Oncology Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Oncology Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Oncology Drugs Market Share Forecast by Type (2019-2024)
12.4 Oncology Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Oncology Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Oncology Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oncology Drugs Picture
Table Product Specifications of Oncology Drugs
Figure Global Sales Market Share of Oncology Drugs by Types in 2018
Table Oncology
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
